Which staging systems are used for ovarian cancer?

Updated: Aug 10, 2020
  • Author: Andrew E Green, MD; Chief Editor: Yukio Sonoda, MD  more...
  • Print

Two major staging systems are commonly used in ovarian cancer, as follows:

  • The International Federation of Gynecology and Obstetrics (FIGO) system, developed in collaboration with the World Health Organization (WHO) and revised in 2014. [131]

  • The TNM system, developed by the International Union Against Cancer (UICC) and the American Joint Committee on Cancer (AJCC); the  8th edition was published in 2017. [132]

  • The TNM and FIGO staging systems for ovarian and primary peritoneal cancer are also used for malignant germ cell tumors, malignant sex cord-stromal tumors, and carcinosarcoma (malignant mixed Müllerian tumors). [131, 132]

For details on these systems, see Ovarian Cancer Staging

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!